Article and Video CATEGORIES

Cancer Journey

Search By

Amy brings over three decades of experience in for-profit and nonprofit business management and ownership. In December 2017, she joined The Global Resource for Advancing Cancer Education as its Executive Director. She directs its growth in strategy, revenue, outreach, partnership, and programs.

 

Meet the 2021 Patient Education Ambassadors!
Author
Amy Bickleman
Image
GRACE is pleased to announce the acceptance of four rising stars into the third year of the GRACE Patient Education Ambassador Program for the 2021-2022 Program Year!

All four candidates have shown a genuine passion for patient education and innovation in connecting with the patient community. The program will encompass the participants creating content that will be featured on the GRACE website, working alongside GRACE faculty, Board and staff, and learning the most current and effective communication skills needed to succeed at connecting and communicating with patients in their field. The program starts July 1, 2021, and ends on June 30, 2022. We are excited to work with them over the next year to continue to educate cancer patients on the most current and emerging treatment options. Watch for new videos, articles, and podcasts featuring the passions that these four amazing fellows have to share with the community!

 


2021 GRACE Patient Education Ambassador Program Winners

Dr. Daniel Kwon  

Dr. Daniel Kwon is a hematology/oncology fellow at the University of California, San Francisco in San Francisco, California.


Dr. Kwon is passionate about improving shared decision-making for patients with cancer. Using implementation science methods, he conducts research to improve patients’ ability to make well-informed, preference-sensitive decisions. Dr. Kwon has led implementation studies of novel communication and decision support tools, such as consultation audio recordings, by leveraging mobile health. He is also interested in biomarkers, survivorship, and health disparities. Dr. Kwon has received several national awards, including the ASCO GU Merit Awards in 2020 and 2021, and the 2021 Conquer Cancer Young Investigator Award to fund a randomized trial of consultation audio recordings in men with advanced prostate cancer. Outside of work, Dr. Kwon enjoys cooking and eating out with his wife and daughter.

Congratulations to Dr. Kwon for being chosen as a winner for the GRACE 2020-21 Patient Education Ambassador program!


Dr. Eric Singhi  

Dr. Eric K. Singhi is a current chief hematology/oncology fellow at MD Anderson Cancer Center in Houston, Texas.

He is a former Internal Medicine resident at Vanderbilt University Medical Center. He has a clinical interest in thoracic medical oncology. He is passionate about medical education and optimizing the cancer patient experience through patient-reported outcomes. 

As a GRACE Patient Education Fellow Ambassador, Dr. Singhi is looking forward to developing creative educational content to engage patients in their care. He has a particular interest in using non-traditional platforms to enhance information sharing and education. 

Outside of work, Dr. Singhi enjoys traveling, cooking new vegetarian dishes, running, watching college basketball, and spending quality time with his family and friends. 


Dr. Aakash Desai  

Dr. Aakash Desai is a first-year hematology-oncology fellow at Mayo Clinic, Rochester. He holds a master’s degree in public health from the University of Texas Health Science Center in Houston and a certification in Health Professions Education from the University of Connecticut. He also serves as a secretary for the Minnesota State Medical Association Resident and Fellow Section. His professional interests include evidence base in oncology, clinical trials, drug development, cancer care quality, and health care delivery. He is one of the founding members of the grassroots consortium focusing on COVID-19 in patients with cancer now known as the COVID19 and Cancer Consortium (CCC19; @COVID19nCCC). Follow him on Twitter @ADesaiMD


Dr. Edina Wang  

Dr. Edina Wang is a radiation oncology resident at Georgetown University Hospital Department of Radiation Medicine in Washington, DC.

Dr. Wang is strongly committed to contributing to education and advocacy initiatives, which are interests that have been driven by times of adversity in her own life. She is active in cancer education for medical students, other physicians, as well as for patients and their caregivers. She serves on the Communications Committee of the American Society of Radiation Oncology (ASTRO). She is the Editor of Special Editions of the ASTRO journal Advances in Radiation Oncology. She has served as the 2020-2021 Radiation Oncology Representative for the American College of Radiology Resident Fellow Section. She has also led diversity, equity, and inclusion initiatives as one of the Co-Chairs of the Curriculum and Evaluation Subcommittee of the MedStar Health Academic Affairs Working Group on Racial Justice (WGRJ).  

What she enjoys most about being a physician is building connections with her patients and providing support during challenging and uncertain times in their lives. 


 
Congratulations Drs. Kwon, Singhi, Desai and Wang!

 

#lilly #exelixis #genentech

 

 

 

 

Video Language

Next Previous link

Previous PostNext Post

Related Content

Image
Blood Cancers OncTalk
Article
Registration is now open! Join us for the annual 2024 Blood Cancers OncTalk!  Register Now!
Image
PEA 2024-25 final
Article
GRACE is pleased to announce the acceptance of five rising stars into the 6th year of the GRACE Patient Education Ambassadors Program for the 2024-25 Program Year! 
Image
2024 patient education ambassadors program
Article
Applications are now open to oncology fellows and finishing fellows Program Information Form and Application

Forum Discussions

Hi elysianfields and welcome to Grace.  I'm sorry to hear about your father's progression. 

 

Unfortunately, lepto remains a difficult area to treat.  Recently FDA approved the combo Lazertinib and Amivantamab...

Hello Janine, thank you for your reply.

Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...

Hi elysianfields,

 

That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...

Hello Linda, my name is Alexandra Beneke, I'm the Outreach Manager for GRACE. Your willingness to share your experiences and knowledge with the cancer community is truly inspiring. Your dedication to...

Recent Comments

JOIN THE CONVERSATION
I could not find any info on…
By JanineT GRACE … on
Hi elysianfields,

 

That's…
By JanineT GRACE … on
Hello Janine, thank you for…
By elysianfields on
EGFR
By happybluesun on